DB Diagnósticos is a leader in the Health Care industry, dedicated to providing exclusive laboratory support without creating competition for its clients. With over 12 years of experience, the company has gained national recognition for its quality, holding accredited certifications such as PALC, DICQ, and ISO, reflecting its high standards in every service offered. The company's extensive and modern infrastructure enables a capacity of conducting 35 million tests monthly, all administered by a highly qualified team. The commitment to staying on top of industry trends drives DB to continuously invest in innovation and technology, focusing on meeting the specific needs of each laboratory and providing the best available solutions to the market. The integrated logistics system and over 40 regional units across the country ensure quick sample collections, reaching the production unit within 24 hours. To efficiently accommodate these demands, DB operates 9 decentralized clinical analysis units and three specialized in molecular, pathological, and toxicological diagnosis, ensuring excellence in every processed test. Founded in 2011 and headquartered in Brazil, DB Diagnósticos stands as a promising investment opportunity for venture capitalists seeking to contribute to the advancement of the healthcare industry.
There is no investment information
No recent news or press coverage available for DB Diagnósticos.